Published in Bioinformatics on June 06, 2007
Using cross-validation to evaluate predictive accuracy of survival risk classifiers based on high-dimensional data. Brief Bioinform (2011) 1.69
CMA: a comprehensive Bioconductor package for supervised classification with high dimensional data. BMC Bioinformatics (2008) 1.68
Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets. PLoS One (2010) 1.58
Survival analysis with high-dimensional covariates. Stat Methods Med Res (2009) 1.50
Voxelwise gene-wide association study (vGeneWAS): multivariate gene-based association testing in 731 elderly subjects. Neuroimage (2011) 1.48
Multilocus genetic analysis of brain images. Front Genet (2011) 1.45
Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines. Genome Biol (2014) 1.43
Optimized application of penalized regression methods to diverse genomic data. Bioinformatics (2011) 1.37
Network-based survival analysis reveals subnetwork signatures for predicting outcomes of ovarian cancer treatment. PLoS Comput Biol (2013) 1.34
CONVERGENCE AND PREDICTION OF PRINCIPAL COMPONENT SCORES IN HIGH-DIMENSIONAL SETTINGS. Ann Stat (2010) 1.31
Flexible boosting of accelerated failure time models. BMC Bioinformatics (2008) 1.26
Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer. PLoS One (2013) 1.22
Gene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancer. PLoS Genet (2009) 1.19
Survival prediction from clinico-genomic models--a comparative study. BMC Bioinformatics (2009) 1.18
Molecular signatures from omics data: from chaos to consensus. Biotechnol J (2012) 1.17
Renal gene and protein expression signatures for prediction of kidney disease progression. Am J Pathol (2009) 1.15
Prognostic microRNAs in cancer tissue from patients operated for pancreatic cancer--five microRNAs in a prognostic index. World J Surg (2012) 1.14
Combining gene signatures improves prediction of breast cancer survival. PLoS One (2011) 1.11
Transforming RNA-Seq data to improve the performance of prognostic gene signatures. PLoS One (2014) 1.10
Time to recurrence and survival in serous ovarian tumors predicted from integrated genomic profiles. PLoS One (2011) 1.09
Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis. Genome Biol (2014) 1.07
A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects. Blood (2008) 1.06
Comparing the characteristics of gene expression profiles derived by univariate and multivariate classification methods. Stat Appl Genet Mol Biol (2008) 1.02
Survival models with preclustered gene groups as covariates. BMC Bioinformatics (2011) 0.98
Metabolomics-based discovery of diagnostic biomarkers for onchocerciasis. PLoS Negl Trop Dis (2010) 0.92
Cancer prognosis using support vector regression in imaging modality. World J Clin Oncol (2011) 0.91
SignS: a parallelized, open-source, freely available, web-based tool for gene selection and molecular signatures for survival and censored data. BMC Bioinformatics (2008) 0.90
High-Dimensional Heteroscedastic Regression with an Application to eQTL Data Analysis. Biometrics (2011) 0.89
Iterative Bayesian Model Averaging: a method for the application of survival analysis to high-dimensional microarray data. BMC Bioinformatics (2009) 0.89
An integrated mRNA and microRNA expression signature for glioblastoma multiforme prognosis. PLoS One (2014) 0.89
Gene Selection using a High-Dimensional Regression Model with Microarrays in Cancer Prognostic Studies. Cancer Inform (2012) 0.88
High-dimensional variable selection in meta-analysis for censored data. Biometrics (2010) 0.86
Biclustering reveals breast cancer tumour subgroups with common clinical features and improves prediction of disease recurrence. BMC Genomics (2013) 0.85
Proceedings of the 2008 MidSouth Computational Biology and Bioinformatics Society (MCBIOS) Conference. BMC Bioinformatics (2008) 0.85
Cross-study validation for the assessment of prediction algorithms. Bioinformatics (2014) 0.85
Internal validation inferences of significant genomic features in genome-wide screening. Comput Stat Data Anal (2009) 0.85
Predicting the survival time for diffuse large B-cell lymphoma using microarray data. J Mol Genet Med (2012) 0.82
Investigating hospital heterogeneity with a multi-state frailty model: application to nosocomial pneumonia disease in intensive care units. BMC Med Res Methodol (2012) 0.81
Development and validation of predictive indices for a continuous outcome using gene expression profiles. Cancer Inform (2010) 0.80
Assessment of reproducibility of cancer survival risk predictions across medical centers. BMC Med Res Methodol (2013) 0.80
Improved classification of breast cancer peptide and protein profiles by combining two serum workup procedures. J Cancer Res Clin Oncol (2012) 0.80
Survival prediction based on compound covariate under Cox proportional hazard models. PLoS One (2012) 0.80
Indirect genomic effects on survival from gene expression data. Genome Biol (2008) 0.80
Dimension reduction of microarray data in the presence of a censored survival response: a simulation study. Stat Appl Genet Mol Biol (2009) 0.79
The Current and Future Use of Ridge Regression for Prediction in Quantitative Genetics. Biomed Res Int (2015) 0.79
Prediction of early breast cancer metastasis from DNA microarray data using high-dimensional cox regression models. Cancer Inform (2015) 0.78
Added predictive value of omics data: specific issues related to validation illustrated by two case studies. BMC Med Res Methodol (2014) 0.78
Survival analysis by penalized regression and matrix factorization. ScientificWorldJournal (2013) 0.78
A three step network based approach (TSNBA) to finding disease molecular signature and key regulators: a case study of IL-1 and TNF-alpha stimulated inflammation. PLoS One (2014) 0.77
Intrinsic bias in breast cancer gene expression data sets. BMC Cancer (2009) 0.77
A Gene Selection Method for Survival Prediction in Diffuse Large B-Cell Lymphomas Patients using 1D Discrete Wavelet Transform. Iran J Public Health (2014) 0.77
Discovering combinatorial interactions in survival data. Bioinformatics (2013) 0.76
Statistical Methods for Establishing Personalized Treatment Rules in Oncology. Biomed Res Int (2015) 0.75
Enhancing the Lasso Approach for Developing a Survival Prediction Model Based on Gene Expression Data. Comput Math Methods Med (2015) 0.75
Application of modified regression techniques to a quantitative assessment for the motor signs of Parkinson's disease. IEEE Trans Neural Syst Rehabil Eng (2009) 0.75
A regression-based differential expression detection algorithm for microarray studies with ultra-low sample size. PLoS One (2015) 0.75
The Spike-and-Slab Lasso Generalized Linear Models for Prediction and Associated Genes Detection. Genetics (2016) 0.75
Predicting the Survival Time for Bladder Cancer Using an Additive Hazards Model in Microarray Data. Iran J Public Health (2016) 0.75
A hybrid approach of gene sets and single genes for the prediction of survival risks with gene expression data. PLoS One (2015) 0.75
Identifying Prognostic SNPs in Clinical Cohorts: Complementing Univariate Analyses by Resampling and Multivariable Modeling. PLoS One (2016) 0.75
Predicting 5-Year Survival Status of Patients with Breast Cancer based on Supervised Wavelet Method. Osong Public Health Res Perspect (2014) 0.75
Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients. Epigenetics (2016) 0.75
Supervised wavelet method to predict patient survival from gene expression data. ScientificWorldJournal (2014) 0.75
Applying a new bilateral mammographic density segmentation method to improve accuracy of breast cancer risk prediction. Int J Comput Assist Radiol Surg (2017) 0.75
Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods. Geburtshilfe Frauenheilkd (2017) 0.75
A data mining approach for identifying pathway-gene biomarkers for predicting clinical outcome: A case study of erlotinib and sorafenib. PLoS One (2017) 0.75
Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors. BMC Genomics (2008) 2.11
IL-18 neutralization during alveolar hypoxia improves left ventricular diastolic function in mice. Acta Physiol (Oxf) (2014) 1.43
Hepatocellular uptake of 3H-dihydromicrocystin-LR, a cyclic peptide toxin. Biochim Biophys Acta (1990) 1.07
Modelling the spread of infectious salmon anaemia among salmon farms based on seaway distances between farms and genetic relationships between infectious salmon anaemia virus isolates. J R Soc Interface (2011) 0.88
Vaccine-associated systemic Rhodococcus erythropolis infection in farmed atlantic salmon Salmo salar. Dis Aquat Organ (2006) 0.83
Behavior of lactating Holstein-Friesian cows during spontaneous cycles of estrus. J Dairy Sci (2011) 0.81
The impact of primary central nervous system lymphoma in AIDS patients: a population-based autopsy study from Oslo. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.80
Genetic variants affecting the neural processing of human facial expressions: evidence using a genome-wide functional imaging approach. Transl Psychiatry (2012) 0.78
Sexually active groups in cattle-a novel estrus sign. J Dairy Sci (2013) 0.78
Gene-expression profiles in hereditary breast cancer. N Engl J Med (2001) 0.76
The structure of abilities in the retarded. Comparison between men and women. Scand J Psychol (1967) 0.75
Accounting for haplotype phase uncertainty in linkage disequilibrium estimation. Genet Epidemiol (2008) 0.75
[Internal lead poisoning in Greenland]. Ugeskr Laeger (1987) 0.75
[Hemodialysis in acute kidney failure and poisoning]. Tidsskr Nor Laegeforen (1968) 0.75
[Gastrointestinal endoscopy in children]. Tidsskr Nor Laegeforen (2000) 0.75
Lack of pro-inflammatory cytokine mobilization predicts poor prognosis in patients with acute heart failure. Cytokine (2013) 0.75